Pegaspargase

From Wikipedia, the free encyclopedia

Pegaspargase
Systematic (IUPAC) name
Pegylated E. coli L-asparagine amidohydrolase
Identifiers
CAS number 130167-69-0
ATC code L01XX24
PubChem  ?
DrugBank BTD00079
Chemical data
Formula C1377H2208N382O442S17 
Mol. mass 31731.9 g/mol
Pharmacokinetic data
Bioavailability  ?
Metabolism  ?
Half life  ?
Excretion  ?
Therapeutic considerations
Pregnancy cat.

?

Legal status
Routes  ?

Pegaspargase is an antineoplastic agent.

It is used in the treatment of acute lymphoblastic leukemia.[1]

It is a form of L-asparaginase[2] which has undergone PEGylation.

[edit] References

  1. ^ Graham ML (2003). "Pegaspargase: a review of clinical studies". Adv. Drug Deliv. Rev. 55 (10): 1293–302. PMID 14499708. 
  2. ^ UNM Cancer Center. Retrieved on 2007-08-28.